Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Wednesday's After-Market Session

Author: Benzinga Insights | February 08, 2023 05:31pm

Gainers

  • 23andMe Holding (NASDAQ:ME) shares moved upwards by 12.3% to $2.83 during Wednesday's after-market session. Trading volume for this security closed at 189.4K, accounting for 7.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.2 billion. The company's, Q3 earnings came out today.
  • Revelation Biosciences (NASDAQ:REVB) stock moved upwards by 11.94% to $6.0. The market value of their outstanding shares is at $4.0 million.
  • Decibel Therapeutics (NASDAQ:DBTX) stock increased by 7.88% to $4.65. The company's market cap stands at $116.0 million.
  • Akanda (NASDAQ:AKAN) stock increased by 7.27% to $0.23. Akanda's trading volume hit 168.1K shares by close, accounting for 3.0% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
  • VYNE Therapeutics (NASDAQ:VYNE) shares moved upwards by 7.19% to $0.28. The company's market cap stands at $16.1 million.
  • Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 7.0% to $0.25. The company's market cap stands at $22.2 million.

Losers

  • aTyr Pharma (NASDAQ:LIFE) shares decreased by 12.6% to $2.08 during Wednesday's after-market session. The market value of their outstanding shares is at $60.3 million.
  • Atara Biotherapeutics (NASDAQ:ATRA) shares fell 8.74% to $4.6. The market value of their outstanding shares is at $436.4 million.
  • Azenta (NASDAQ:AZTA) shares decreased by 6.78% to $52.41. The market value of their outstanding shares is at $3.6 billion. As per the news, the Q1 earnings report came out today.
  • Athersys (NASDAQ:ATHX) stock declined by 6.05% to $1.71. The company's market cap stands at $29.4 million.
  • Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock decreased by 5.69% to $1.99. The company's market cap stands at $18.9 million.
  • Gracell Biotechnologies (NASDAQ:GRCL) stock declined by 5.4% to $2.28. The company's market cap stands at $154.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AKAN ATHX ATRA AZTA CDIO DBTX GRCL LIFE ME REVB RUBY VYNE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist